Recurrent Malignant Glioma - Pipeline Review, H1 2013 - New Report Available
Global Markets Direct's, 'Recurrent Malignant Glioma - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Recurrent Malignant Glioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Recurrent Malignant Glioma. Recurrent Malignant Glioma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release